Abstract P2-09-05: LCCC 1525: A phase II study of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer (mTNBC)CK Anders,D Moore,M Sambade, L Cuaboy, A Garrett,M Woodcock, K McKinnon, K Cowens,D Bortone,B Calhoun,L Carey,C Dees,T Jolly,H Muss,K Reeder-Hayes, R Kaltman,R Jankowitz, V Gudena, O Olajide,C Perou,B Vincent,J SerodyPoster Session Abstracts（2019）引用 2|浏览12暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
